what is crypto assets, Knowledge

Defender said that Li Tie had not decided whether to appeal, and Li Tie's defender was interviewed by CCTV reporters outside the court. Regarding the first-instance judgment that Li Tie was sentenced to 20 years, the defender said that Li Tie had not decided whether to appeal, and he would negotiate with Li Tie again. Regarding the state of Li Tie's trial today, the defender's answer is: calm, peaceful and stable. (Tiantian Sports)CEO of Cloud Whale Intelligence responded to layoffs: In order to optimize the organizational structure, it was streamlined from 1,600 to 1,400. Zhang Junbin, CEO of Cloud Whale Intelligence, recently issued a statement in a circle of friends, responding to previous reports of layoffs: "The company's personnel adjustment is to optimize the organizational structure and improve organizational efficiency." According to Zhang Junbin, the company was downsized from the original 1,600 to 1,400, which was not a large-scale layoff. Previously, a number of insiders and employees of Cloud Whale Intelligence revealed to Sina Technology that the company has recently started a major layoff. This round of layoffs involves a wide range of business departments, including development departments, testing departments, etc., and in groups, some groups directly cut their staff by half, and extreme groups cut their staff by 65%. In addition, the company's 12 director-level leaders, three of whom left in the past year, "is very mobile." (Sina Technology)Goldman Sachs lowered the UK's GDP growth forecast for 2024 from the previous 1.2% to 1.0%.

Today, Shengguang Group bought 170 million yuan and sold 171 million yuan at the daily limit, with a turnover of 6.558 billion yuan and a turnover rate of 3.239%. After-hours data show that the special seats of Shenzhen Stock Connect bought 170 million yuan and sold 171 million yuan.Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.Wuzhong, Jiangsu; Dobutamine Hydrochloride Injection and Paramivir Injection are planned to win the bid for the national centralized drug procurement. Jiangsu Wuzhong announced that in the national centralized drug procurement, the bid price of Dobutamine Hydrochloride Injection and Paramivir Injection is 3.58 yuan and 7.47 yuan respectively. The procurement cycle of the two products is until December 31, 2027, and they are supplied to Fujian, Anhui, Jilin, Hubei, Beijing, Inner Mongolia and other provinces and cities respectively. Winning the bid will help to expand the sales of related products, improve market share and brand influence, and have a positive impact on the company's future business performance.

Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.From January to October, the total output of lithium batteries in China increased by 16% year-on-year. According to the Ministry of Industry and Information Technology, China's lithium-ion battery industry continued to grow from January to October 2024. According to the announcement of lithium battery industry norms, enterprise information and industry associations, the total output of lithium batteries in China from January to October was 890GWh, up 16% year-on-year. According to the data of the National Bureau of Statistics, the profit of China's lithium battery manufacturing industry increased by 39.4% from January to October. In the battery sector, the output of energy storage lithium batteries exceeded 200GWh from January to October. The loading capacity of power lithium batteries for new energy vehicles is about 405GWh. From January to October, the total export of lithium batteries in China reached 350.2 billion yuan, down 9.2% year-on-year, and the decline was 3.3 percentage points narrower than that in January-June.The head of the region said that the Russian attack on the key infrastructure in the Ivano-Frankov region was the biggest attack on the region so far.